|
Metabolic outcomes a
|
DM use
| |
Analysis Population
| |
Boys
| |
Girls
|
|---|
|
N
|
Unadjusted OR (95% CI)
|
N
|
Adjusted OR (95% CI) b
|
N
|
Adjusted OR (95% CI) c
|
N
|
Adjusted OR (95% CI) c
|
|---|
|
Abdominal obesity
|
Slope d
|
8114
|
1.00 (0.89–1.13)
|
7966
|
1.05 (0.92–1.19)
|
3966
|
0.97 (0.81–1.16)
|
4000
|
1.12 (0.94–1.34)
|
|
Intercept
| |
1.49 (1.32–1.67)
| |
1.53 (1.35–1.75)
| |
1.30 (1.09–1.56)
| |
1.85 (1.53–2.24)
|
|
High BP e
|
Slope
|
8425
|
1.01 (0.89–1.14)
|
7693
|
1.04 (0.91–1.20)
|
3809
|
1.13 (0.94–1.36)
|
3884
|
0.96 (0.78–1.17)
|
|
Intercept
| |
1.18 (1.04–1.33)
| |
1.08 (0.94–1.25)
| |
1.15 (0.96–1.38)
| |
1.01 (0.81–1.26)
|
|
Dyslipidemia
|
Slope
|
6248
|
1.07 (0.93–1.23)
|
5001
|
1.00 (0.85–1.18)
|
2469
|
1.04 (0.82–1.32)
|
2532
|
0.93 (0.73–1.17)
|
|
Intercept
| |
1.30 (1.14–1.48)
| |
1.28 (1.08–1.51)
| |
1. 42 (1.13–1.78)
| |
1.08 (0.84–1.39)
|
|
Insulin resistance
|
Slope
|
6797
|
0.96 (0.85–1.09)
|
5435
|
1.00 (0.87–1.16)
|
2728
|
1.22 (1.00–1.50)
|
2707
|
0.83 (0.68–1.02)
|
|
Intercept
| |
1.35 (1.20–1.52)
| |
1.16 (1.00–1.35)
| |
1.15 (0.93–1.41)
| |
1.12 (0.90–1.41)
|
|
MetS
|
Slope
|
6843
|
1.21 (1.01–1.46)
|
5288
|
1.30 (1.04–1.62)
|
2636
|
1.62 (1.17–2.24)
|
2652
|
1.08 (0.80–1.47)
|
|
Intercept
| |
1.55 (1.30–1.84)
| |
1.50 (1.21–1.85)
| |
1.58 (1.20–2.11)
| |
1.35 (0.97–1.87)
|
- a The reference category for the metabolic outcomes is below the monitoring level
- b Models are adjusted for age (continuous), sex, pubertal status, country, parental ISCED, HDAS, snack frequency intake, observation period, and abdominal obesity (when BP, IR and dyslipidemia were modeled). Bold significance is provided via confidence limits
- c Models are adjusted for all covariates, besides sex (and physical activity variables)
- d Slope was used as a categorical variable (above vs. below population mean random slope)
- e BP-blood pressure, MetS- metabolic syndrome, DM- digital media
